ConductScience.org, home

Gene · 1263

Papers1,568

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Induced ocular higher-order aberrations after PRK vs LASIK for myopia: systematic review and meta-analysis.J Cataract Refract Surg202742622059PubTator, text miningPubMed
Iron-enhanced rTCA cycle drives synergistic enhancement of inorganic carbon fixation and denitrification.Water Res202642767070PubTator, text miningPubMed
Analysis of hypoxia-inducible factors in the deep-sea fish reveals genetic adaptation to hypoxic environments.Zool Res202642706785PubTator, text miningPubMed
Early Visual, Refractive, and Astigmatism Vector Outcomes of StreamLight Trans-PRK for High Astigmatism (≥ 2.00 D).Rom J Ophthalmol202642572681PubTator, text miningPubMed
Cell-cycle-dependent regulation of DNA end resection by PLK1 and PLK3 without CtIP level modulation.iScience202642436985PubTator, text miningPubMed
Inflammatory and Anti-Inflammatory Response of the Ocular Surface After Excimer Laser Treatment.Biomedicines202642351765PubTator, text miningPubMed
Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.Curr Opin Ophthalmol202642348672PubTator, text miningPubMed
Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.ACS Med Chem Lett202642305216PubTator, text miningPubMed
Ventilation-Associated Differences in Lower Airway Microbial Signatures and Peripheral Blood Transcriptome Among Critically Ill COVID-19 Patients.Infect Drug Resist202642293984PubTator, text miningPubMed
Retreatment using LASIK, PRK, or ICL for myopic regression after corneal laser refractive surgery.BMC Ophthalmol202642260445PubTator, text miningPubMed
Comparative clinical outcomes of SMILE, femtosecond LASIK, and transepithelial PRK: a multicenter Iraqi study.Front Ophthalmol (Lausanne)202642058504PubTator, text miningPubMed
Correction: Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.J Exp Clin Cancer Res202642010615PubTator, text miningPubMed
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English.J Vis Exp202642008362PubTator, text miningPubMed
Transcriptomic evidence of remodeling in postpartum levator ani muscle associated with maternal age and recovery time after first vaginal delivery.Am J Obstet Gynecol202641997518PubTator, text miningPubMed
Single-cell analysis of a salmonid immune system (river brown trout Salmo trutta fario) reveals evolutionary divergence and hatchery-induced transcriptional reprogramming.BMC Biol202641845393PubTator, text miningPubMed
Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications.J Clin Med202641753041PubTator, text miningPubMed
Redox Imbalance and Genetic Mutations in Heart Failure: Synergistic Mechanisms and Therapeutic Strategies.Genes (Basel)202641751609PubTator, text miningPubMed
Oxidative Stress, Pro-Inflammatory Response, Cytotoxicity and Apoptosis Induced by Contemporary Endodontic Sealers in Human Periodontal Ligament Fibroblasts.J Funct Biomater202641745567PubTator, text miningPubMed
Arbuscular Mycorrhizal Fungi-Mediated Reconfiguration of Poplar Leaf C-N-P Metabolic Networks: Environment-Dependent Synergies and Nutrient Interactions.J Fungi (Basel)202641745248PubTator, text miningPubMed
Longitudinal changes in corneal epithelial thickness after FS-LASIK, keratorefractive lenticule extraction, and transepithelial PRK: systematic review and meta-analysis.J Cataract Refract Surg202641739913PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1263/papers